Influencing factors of hungry bone syndrome in maintenance hemodialysis patients after parathyroidectomy

Objective To investigate the influencing factors of hungry bone syndrome (HBS) in maintenance hemodialysis patients with secondary hyperparathyroidism (SHPT) after parathyroidectomy (PTX). Methods A retrospective study was conducted on maintenance hemodialysis patients with SHPT undergoing successful parathyroidectomy with autotransplantation. Clinical data and perioperative indicators of the selected patients were collected. The enrolled patients were divided into HBS group and non-HBS group based on whether the lowest level of blood calcium less than 2.0 mmol/L after surgery. The difference of general clinical data and perioperative indicators between the two groups were compared. The risk factors of HBS were analyzed by logistic regression analysis. Multiple linear regression method was used to analyze the independent factors affecting the maintenance time of intravenous calcium supplementation, the total amount of calcium supplementation during intravenous calcium supplementation and the highest serum level of potassium within 24 h after surgery. Results A total of 306 patients were included in the study. All patients had low levels of serum calcium after operation. There were 230 patients (75.16%) with the lowest blood calcium＜2.00 mmol/L after PTX (HBS group), and 76(24.84%) cases in the non-HBS group. Predialysis coefficient of serum calcium=(preoperative blood calcium-2.20) mmol/L÷0.01 mmol/L. Logistic regression analysis showed that higher predialysis coefficient of serum calcium (B=-0.063, OR=0.939, 95%CI 0.894-0.987, P=0.013) and lower level of preoperative serum alkaline phosphatase (ALP) (B=0.035, OR=1.033, 95%CI 1.019-1.050, P＜0.001) were independent risk factors for HBS. Multiple linear regression analysis revealed that preoperative blood intact parathyroid hormone (iPTH) (B=0.017, P＜0.001 and B=0.041, P＜0.001), preoperative serum ALP (B=0.052, P＜0.001 and B=0.107, P＜0.001) and preoperative hemoglobin (Hb) (B=-0.453, P=0.041 and B=-1.058, P=0.007) were independent factors affecting the maintenance time of intravenous calcium supplementation and the total amount of calcium supplementation in HBS patients. Preoperative predialysis level of serum potassium (B=0.859, P＜0.001) was the independent influencing factor of the maximum level of serum potassium within 24 hours after surgery. Conclusions Patients with lower levels of preoperative serum calcium and higher levels of serum ALP are prone to HBS after PTX. Postoperative calcium supplementation may need to be strengthened in HBS patients with higher preoperative iPTH and ALP levels and lower preoperative Hb levels. High preoperative basal potassium levels may increase the risk of hyperkalemia after PTX.     

甲状旁腺全切＋自体移植术治疗继发性甲状旁腺功能亢进症疗效分析

目的探讨甲状旁腺全切＋自体移植术(tPTX＋AT)治疗维持性血液透析患者继发性甲状旁腺功能亢进症(SHPT)的有效性、安全性以及术后低钙的危险因素。 方法纳入我院2013年1月至2016年11月因SHPT行tPTX＋AT手术的维持性血液透析患者93例,收集术前术后症状、血钙、磷、碱性磷酸酶(ALP)、全段甲状旁腺激素(iPTH)、病理类型、并发症等临床资料。依据术后24 h血钙水平分为正常血钙组(Ca≥2.11 mmol/L)及低钙血症组(Ca<2.11 mmol/L),应用单因素分析及逐步Logistic回归分析术后早期低钙血症的危险因素。 结果手术成功率92.5%。切除360枚甲状旁腺腺体,异位甲状旁腺10枚。病理结果多为腺瘤样增生(96.4%)。同术前相比,术后血清iPTH、磷、ALP明显下降(P<0.05)。低钙血症是术后最常见并发症,发生率82.8%,血钙水平与术前血钙、年龄正相关(r＝0.300, P<0.01;r＝0.265, P<0.01),与术前iPTH、ALP水平负相关(r＝－0.461, P<0.01;r＝－0.477, P<0.01)。术前低血钙(OR＝0.113, P＝0.045)、高ALP水平(OR＝1.050, P<0.001)、高iPTH水平(OR＝1.002, P＝0.004)是术后早期低钙血症发生的独立危险因素。 结论tPTX＋AT可以安全、有效、快速的降低维持性血液透析患者血清iPTH水平,改善机体的钙磷代谢紊乱,但需重视并积极纠正术后低钙血症。针对存在术前低血钙、高iPTH及高ALP水平等高危因素的患者,术前积极纠正低钙血症可能是预防术后低钙的有效干预方式。     

全髋关节置换术患者延迟出院的危险因素分析

目的分析全髋关节置换术患者延迟出院的危险因素。方法回顾性分析2015年1月至2018年7月择期行单侧全髋关节置换术患者的临床资料,包括性别、年龄、BMI、ASA分级、手术时间、麻醉方式、术中失血量、术中输液量、术中阿片类药物用量、术中血管活性药物用量、PACU停留时间、术后随访静息疼痛评分、术前住院时间、术前合并症、术后并发症及转归情况。根据术后住院时间将患者分为两组:正常出院组(术后住院时间≤14 d)和延迟出院组(术后住院时间>14 d),采用单因素和多因素Logistic回归分析影响延迟出院的因素。结果共纳入908例患者。单因素分析显示,与正常出院组比较,延迟出院组的年龄明显偏高,术中失血量明显增多,手术时间、PACU停留时间、术前住院时间明显延长,术前合并症、术后并发症明显增多(P<0.05)。Logistic回归分析显示,年龄≥70岁(OR=2.075,95%CI 1.287~3.346,P=0.003)、手术时间>3 h(OR=1.997,95%CI 1.181~3.375,P=0.010)、术中失血量≥800 ml(OR=2.898,95%CI 1.449~5.794,P=0.003)、PACU时间>60 min(OR=1.745,95%CI 1.064~2.859,P=0.027)、术前住院时间≥7 d(OR=1.805,95%CI 1.114~2.924,P=0.016)、术前有合并症≥2个(OR=2.912,95%CI 1.513~5.825,P=0.003)是导致患者延迟出院的独立危险因素。结论患者年龄、术中失血量、手术时间、PACU停留时间、术前住院时间及术前合并症是全髋关节置换术后出院延迟的独立危险因素,针对危险因素进行有效干预是缩短住院时间改善患者预后的重要策略。     

Correlation analysis between homocysteine level and acute kidney injury after cardiac valve replacement surgery

Objective To investigate the relationship between preoperative serum homocysteine (Hcy) level and acute kidney injury (AKI) after cardiac valve replacement surgery. Methods The data of the inpatients who accepted cardiac valve replacement surgery, age ≥18 years, no renal replacement therapy before surgery, non-renal decompensation and preoperative serum creatinine (Scr)＜178 μmol/L, survival within 48 h after surgery, and with preoperative serum Hcy data in the First Affiliated Hospital of Guangxi Medical University from January 1, 2015 to December 31, 2017 was retrospectively analyzed. AKI was diagnosed in patients whose Scr increased more than 26.5 μmol/L (0.3 mg/dl) within 48 hours or 1.5 times higher than baseline within 7 days after surgery. According to this, patients were divided into AKI group and non-AKI group, and the affecting factors for AKI were compared between the two groups. Multivariate logistic regression was used to analyze the independent influencing factors of AKI. The relationship between serum Hcy level and AKI incidence was analyzed by Spearman correlation analysis. Whether the AKI occurred and serum Hcy levels were used as variables to map the receiver operating characteristic curve (ROC), and was used to assess the value of preoperative serum Hcy level for predicting AKI after cardiac valve replacement surgery. Results A total of 810 subjects were included in the study, including 375 males and 435 females. They were (50±11) years old (19-78 years old). Among them, 329 patients with AKI occurred within 7 days after heart valve replacement, and the incidence rate was 40.6% (male 45.9%, female 36.1%). The serum Hcy level in the AKI group was higher than that in the non-AKI group [(15.74±4.55) μmol/L vs (13.87±3.85) μmol/L, t=6.106, P＜0.01]. Multivariate logistic regression analysis showed age (OR=1.030, 95%CI 1.014-1.045, P＜0.001), extracorporeal circulation time (OR=1.011, 95%CI 1.007-1.016, P＜0.001), Scr (OR=1.014, 95%CI 1.005-1.023, P=0.002), serum Hcy (OR=1.059, 95% CI 1.017-1.103, P=0.006), high level of Hcy (＞13.64 μmol/L) (OR=1.465, 95%CI 1.059-2.027, P=0.021) and moderate to severe hyperhomocystinemia (16≤Hcy≤100 μmol/L) [with normal HHcy (Hcy＜10 μmol/L) as reference, OR=2.180, 95%CI 1.245-3.816, P=0.006] were independent influencing factors of AKI after cardiac valve replacement surgery. Spearman correlation analysis showed that the incidence of postoperative AKI increased with the increase of preoperative serum Hcy level (rs=0.927, P＜0.001). The results of ROC curve showed that the area under the curve of the preoperative serum Hcy level predicting AKI after heart valve replacement was 0.701, and the cutoff value was 13.64 μmol/L, with the sensitivity 61.3%, specificity 70.9%. Conclusions Preoperative serum Hcy level is an influencing factor for AKI after cardiac valve replacement surgery. The higher the level of preoperative serum Hcy, the higher the incidence of AKI after cardiac valve replacement surgery. Patients with preoperative serum Hcy levels＞13.64 μmol/L have an increased risk of AKI after cardiac valve replacement surgery.     

Clinical and pathological features of hyperuricemia in children with IgA nephropathy at a single center

Objective To investigate the clinical, pathological features and risk factors of hyperuricemia in children with IgA nephropathy (IgAN). Methods A retrospective study of 269 primary IgAN children diagnosed between January 1, 2006 to December 31, 2017 at the Children Kidney Disease Center, the First Affiliated Hospital of Sun Yat-sen University, was performed in the hyperuricemia group (uric acid＞350 μmol/L) and the normal uric acid group. The clinical and pathological characteristics were analyzed, and the risk factors of hyperuricemia were analyzed by using multivariate logistic regression analysis. Results There were 185 males and 84 females in the 269 IgAN children with age of (9.2±3.1) years old, among whom there were 70 patients (26.0%) accompanied by hyperuricemia. Clinical indicators such as hypertension, urea nitrogen, serum creatinine, blood lipids, urinary protein in hyperuricemia group were higher than those in normal uric acid group (all P＜0.05), while estimated glomerular filtration rate, serum total protein and albumin were less (all P＜0.05). There were 58 patients (23.0%) and 12 patients (70.5%) associated with hyperuricemia among IgAN children with CKD 1-2 and CKD 3-5. The proportion of hyperuricemia in CKD stage 3-5 IgAN children was statistically higher than that in normal uric acid group (P＜0.01). The hyperuricemia group had a higher proportion of Lee IV and V grade, and a lower proportion of the Lee III grade than the normal uric acid group (all P＜0.05). According to the Oxford pathological classification score, there was no significant difference in total scores of renal lesions, glomerular score, and tubulointerstitial score between the two groups (all P＞0.05). According to the Katafuchi semi-quantitative score, there was no significant difference in the total scores of renal lesions, glomeruli, and tubulointerstitial scores (all P＞0.05), while the hyperuricemia group had higher renal vascular scores than the normal uric acid group (P＜0.01). Multivariate logistic regression analysis showed that hypertension (OR=12.596, 95%CI 1.778-89.243, P=0.011), higher total cholesterol (OR=1.192, 95%CI 1.064-1.336, P=0.002), higher urea nitrogen (OR=1.273, 95%CI 1.104-1.468, P=0.001), proteinuria 3+(OR=1.875, 95%CI 1.309-2.684, P=0.001), proteinuria 4+(OR=1.627, 95%CI 1.241-2.134, P＜0.001) and CKD stage 3 (OR=3.355, 95%CI 1.376-8.181, P=0.008) were the risk factors of hyperuricemia in children with IgAN. Conclusions Twenty-six percent IgAN children patients are accompanied by hyperuricemia, and their clinical parameters and pathological changes are more severe than those in normal uric acid group. Hypertension, higher total cholesterol, higher urea nitrogen, proteinuria 3+/4+ and CKD stage 3 are the risk factors of hyperuricemia in children with IgAN.     

�������������������Σ�����ط�������303�������������棩

??Related risk factors of pancreatic fistula after pancreatic surgery: A report of 303 cases LIU Bao-chuan??GE Chun-lin. Department of Pancreatic Surgery, the First Affiliated Hospital of China Medical University??Shenyang 110001??China
Corresponding author??GE Chun-lin??E-mail??gechunlin@139.com
Abstract Objective To investigate the risk factors of pancreatic fistula in patients after pancreatic operation. Methods The clinical data of 303 cases of pancreatic operation performed from February 2012 to January 2015 in the First Hospital of China Medical University were analyzed retrospectively, included 50 postoperative pancreatic Fistula cases. The potential risk factors of pancreatic fistula were analyzed by univariate and multivariate Logistic regression analysis. Results The univariate analysis showed that the risk factors of pancreatic fistula included sex, pathological type, dilatation of pancreatic duct, operation time, intraoperative blood loss, preoperative Hb, preoperative and postoperative serum TBIL??P<0.05??. The multivariate nonconditional Logistic regression analysis showed that the risk factors of pancreatic fistula included gender??OR??12.001??95%CI 3.049—47.230??P=0.00??, duodenal cancer and vater cancer in pathological diagnosis??OR??1.605??95%CI=1.108—2.324??P=0.00??, dilatation of pancreatic duct??OR??1.177??95%CI 0.188—0.468??P=0.00??, time of surgery??OR=1.641??95%CI 1.173—2.339??P=0.00??,intraoperative blood loss??OR=1.096??95%CI 1.094—1.099??P=0.00??,preoperative hemoglobin??OR=0.888??95%CI 0.823—0.921??P=0.00??, preoperative serum total bilirubin??OR=1.359??95%CI 1.335—1.381??P=0.00??, postoperative serum total bilirubin??OR=1.030??95%CI 1.064—1.004??P=0.00??. Conclusion Male??high serum total bilirubin before and after surgery, duodenal cancer and vater cancer in pathological diagnosis are independent risk factors of the incidence of pancreatic fistula??and dilatation of the main pancreatic duct can reduce the risk of pancreatic fistula.     

Risk factors for hypocalcemia in dialysis patients with refractory secondary hyperparathyroidism after parathyroidectomy: a meta-analysis

ObjectiveHypocalcemia after parathyroidectomy (PTX) results in tetany, diarrhea, cardiac arrhythmia, and even sudden death. However, a meta-analysis or systematic evaluation of risk factors with the occurrence and development of hypocalcemia in patients with secondary hyperparathyroidism (SHPT) after PTX has never been performed.MethodsA thorough search of electronic databases, including PubMed, Web of Science, the Cochrane Library, and EMBASE, was performed to retrieve relevant studies from database inception to June 2021. Quality of the included studies was assessed by two independent reviewers using the Newcastle–Ottawa Scale. Review Manager 5.3 and Stata 16.0 were used for meta-analysis. The random-effects model was adopted to calculate the 95% CIs (I²> 50% or p < 0.05) of the combined effect size and the corresponding homogeneous data. Otherwise, a fixed-effects model was used.ResultsThirteen studies including 2990 participants who met the inclusion criteria were enrolled in the present meta-analysis. The overall quality of the enrolled studies had a score of >7 points. Risk factors significantly related to hypocalcemia in patients with SHPT after PTX were preoperative serum calcium (OR 0.19, 95%CI 0.11–0.31), preoperative alkaline phosphatase (ALP) (OR 1.01, 95% CI 1.01–1.02), and preoperative intact parathyroid hormone (iPTH) (OR 1.38, 95%CI 1.20–1.58). Meanwhile, age (OR 0.97, 95%CI 0.87–1.10) was not significantly correlated with hypocalcemia after PTX.ConclusionsBased on the current evidence, preoperative serum calcium, preoperative ALP, and preoperative iPTH were significant predictors of hypocalcemia in patients with SHPT after PTX. More attention should be given to patients with these risk factors for the prevention of postoperative hypocalcemia.     

输尿管镜钬激光碎石术治疗输尿管结石术后发热的危险因素分析

目的探讨输尿管镜钬激光碎石术治疗输尿管结石术后发热的危险因素。 方法回顾性分析2013年1月至2016年12月榆林市星元医院行输尿管镜钬激光碎石术治疗的输尿管结石患者568例,通过非条件Logistic回归,分析造成输尿管结石患者输尿管镜钬激光碎石术术后发热的危险因素。 结果术后共发现发热患者60例（10.56%）。导致输尿管结石患者输尿管镜钬激光碎石术术后发热的危险性因素依次为：女性（OR=1.266,95%CI=1.106～1.865,P=0.02）、术前尿白细胞计数增高（OR=2.296,95%CI=1.856～5.156,P<0.01）、术前尿培养细菌阳性（OR=1.115,95%CI=1.005～1.568,P<0.01）、灌注时间过长（OR=1.226,95%CI=1.098～1.704,P=0.03）、手术时间过长（OR=1.328,95%CI=1.167～1.969,P=0.03）。 结论对于女性、术前尿白细胞计数过多、术前尿培养细菌阳性、灌注时间过长、手术时间过长者,应积极防治输尿管镜钬激光碎石术术后发热。     

胃切除术后胃排空障碍危险因素的Meta分析

目的 探讨胃切除术后胃排空障碍的危险因素.方法 检索中国期刊全文数据库（CNKI）、中国生物医学文献数据库、万方数据库、学位论文数据库与重要会议论文数据库以及Medline数据库2003—2013年期间公开发表的有关胃切除术后胃排空障碍危险因素的文献,提取文献资料,采用RevMan5.0软件分析胃排空障碍的相关危险因素.结果 19篇文献共9976例胃切除患者纳入分析,术后胃瘫572例（5.85％）.60岁以上高龄患者（P＜0.01,OR=1.65,95％CI：1.31～2.09）、术前贫血（P=0.01,OR=1.48,95％CI：1.08～2.02）、术前存在胃肠道梗阻（P＜0.01,OR=3.72,95％CI：3.05～4.55）、毕Ⅱ式吻合（P＜0.01,OR=3.35,95％CI：2.72～4.13）、术后应用镇痛泵（P＜0.01,OR=1.74,95％CI：1.33～2.26）、围手术期血糖超过8 mmol/L（P＜0.01,OR=2.64,95％CI：2.00～3.49）、术后白蛋白水平低于30 g/L （P＜0.01,OR=2.13,95％CI：1.62～2.79）、术后出现腹腔并发症（P＜0.01,OR=2.41,95％CI：1.77～3.29）及存在不良心理反应者（P＜0.01,OR=5.94,95％CI：1.79～19.73）术后胃排空障碍发生率明显升高;而性别、手术时间、术中出血量、手术时机及根治与否则与胃排空障碍发生无关（均P＞0.05）.结论 年龄、术前存在胃肠道梗阻、消化道重建方式、术后镇痛泵的应用、围手术期血糖和白蛋白水平、术后腹腔并发症以及患者心理状态是胃切除术后胃排空障碍的可能危险因素.     

Correlation between pathological types of parathyroid and clinical manifestations in patients with renal secondary hyperparathyroidism

Objective To analyze the correlation between the pathological types of parathyroid and clinical manifestations in patients with renal secondary hyperparathyroidism (SHPT), so as to improve the efficacy and safety of treatment. Methods The pathological and clinical data of 130 patients with renal SHPT and maintenance hemodialysis (MHD) who had undergone total parathyroidectomy with autotransplantation (TPTX+AT) were collected. A total of 545 parathyroid glands were obtained and 998 slices were made and read. According to the pathological types of parathyroid hyperplasia, the patients were divided into diffuse hyperplasia (DH) group, diffuse between hyperplasia and nodular hyperplasia (DH/NH) group as well as nodular hyperplasia (NH) group. The clinical and biochemical characteristics of different groups before and after operation (1-, 3-, 6-, 9-, 12-month) were compared and analyzed by statistical tests. Results (1) The preoperative status: the dialysis age, serum calcium as well as incidence of bone pain, skin itching and shorten height in the NH group were significantly higher than those in the DH group (all P＜0.05), and the serum phosphorus and iPTH in the NH group were significantly higher than those in DH and DH/NH group (all P＜0.05). (2) The postoperative status: the serum calcium of the NH group at 1-month was lower than that of the DH group, and the incidence of hypocalcemia of the NH group at 1-month was higher than that of the DH group (P＜0.05); the serum phosphorus at 3-, 6-, 9-month and iPTH at 1-, 3-month of the NH group were significantly lower than that of the DH group (all P＜0.05), and the serum phosphorus at 3-month and iPTH at 1-month of the NH group were lower than that of the DH/NH group (all P＜0.05). Among the 3 groups the serum phosphorus change from 1 to 12 months had difference (F=3.241, P=0.042), while the differences of serum calcium and iPTH changes were statistically insignificant. Conclusions The clinical manifestations, serum calcium, phosphorus and iPTH in patients with renal SHPT before and after TPTX+AT are closely related to the pathological types of parathyroid hyperplasia. Compared with the DH patients, before the operation the NH patients have longer dialysis age, more serious the clinical symptoms such as bone disease, higher calcium, phosphorus and iPTH, while greater reduction of the serum calcium, phosphorus and iPTH in the short term after operation.     

Clinical analysis of 1 371 patients with acute kidney injury after acute myocardial infarction

Objective To investigate the risk factors of acute kidney injury (AKI) in patients after acute myocardial infarction (AMI). Methods A total of 1 371 adult patients diagnosed AMI in the First People's Hospital of Changzhou from January 2008 to December 2012 were analyzed retrospectively. AKI was defined according to the 2012 KDIGO AKI criteria. Based on the occurrence of AKI, the patients were divided into AKI group and non-AKI group. According to the AKI timing, the patients were divided into subgroups including conservative treatment groups, coronary angiography(CAG) groups and coronary artery bypass grafting (CABG) groups, respectively. Related risk factors of AKI were analyzed by univariate and multivariate logistic regression. Results Of the 1 371 patients,410(29.9%) developed AKI. Compared to the non-AKI group, in-hospital mortality increased significantly in the AKI group (17.1% vs 3.9%, χ2=68.0, P＜0.001). Multifactor retrospective analysis showed that decreased baseline eGFR (OR=2.049, 95%CI: 1.246-3.370), increased fasting plasma glucose(FPG) (OR=1.070, 95%CI: 1.018-1.124), diuretics (OR=1.867, 95%CI: 1.220-2.856) and Killip class 4 status (OR=1.362, 95%CI: 1.059-3.170) were all independent risk factors of AKI, while increased DBP on admission was a protective factor (OR=0.986, 95%CI: 0.974-0.998) for the conservative management group. Decreased baseline eGFR (OR=2.371, 95%CI: 1.500-3.747), increased FPG(OR=1.009, 95%CI: 1.005-1.012), diuretics (OR=1.674, 95%CI: 1.042-2.690), intraoperative hypotension (OR=2.276, 95%CI: 1.324-3.575) and acute infection (OR=1.678, 95%CI: 1.023-2.754) were independent risk factors of AKI for the CAG group. Decreased baseline eGFR (OR=2.246, 95%CI:1.340-3.981), increased FPG (OR=1.059, 95%CI: 1.018-1.124), diuretics (OR=1.723, 95%CI: 1.122-2.650), and low cardiac output syndrome after operation (OR=2.331, 95%CI: 1.277-3.286) were independent risk factors of AKI for CABG group. Conclusions AKI is a common complication and associated with increased mortality after AMI. Decreased baseline renal function, increased FPG and diuretics were common independent risk factors of AKI after AMI.     

The risk factors of mortality in peritoneal dialysis patients in different periods

Objective To explore the risk factors and characteristics in patients with peritoneal dialysis who died in different periods. Methods The clinical data of new peritoneal dialysis patients in the Department of Nephrology and Peritoneal Dialysis Center of the First Affiliated Hospital of Nanchang University from November 1, 2005 to February 28, 2017 was retrospectively analyzed. The patients were divided into two groups according to the time of death: those who died within one year and died after one year. The risk factors of mortality between the two groups were analyzed by Cox regression model. Results A total of 997 patients were enrolled and 244 patients died. There were 69 patients (28.3%) died within one year and 175 patients (71.7%) died after one year. Cardiovascular and cerebrovascular disease was the dominating reason of death in both groups, accounting for 59.4% (died within one year group) and 51.4% (died after one year group) respectively. Cox regression analysis showed that for died within one year group, old age (HR=1.035, 95%CI: 1.016-1.055, P＜0.001), low blood total calcium (HR=0.167, 95%CI: 0.053-0.529, P=0.002), low albumin (HR=0.899, 95%CI: 0.856-0.943, P＜0.001) and low apolipoprotein A1 (HR=0.274, 95%CI: 0.095-0.789, P=0.016) were risk factors associated with mortality. However, for died after one year group, old age (HR=1.053, 95%CI: 1.038-1.069, P＜0.001), combined with diabetes (HR=2.181, 95%CI: 1.445-3.291, P＜0.001) and hypertriglyceride (HR=1.204, 95%CI: 1.065-1.362, P=0.003) were risk factors associated with mortality. Conclusions The risk factors of mortality for peritoneal dialysis patients of different periods were not exactly the same. For died within one year patients, old age, low blood total calcium, low albumin and low apolipoprotein A1 were independent risk factors for mortality.However, for died after one year patients, old age, combined with diabetes, and high triglycerides were independent risk factors for mortality.     

Multicenter study on the influencing factors of interdialysis blood pressure variability in maintenance hemodialysis patients

Objective To assess the influencing factors of interdialysis blood pressure variability (BPV) in maintenance hemodialysis (MHD) patients from Pearl River Delta, and provide clinically useful information for the prevention and treatment of BPV. Methods MHD patients in 10 hemodialysis centers from Pearl River Delta were enrolled and analyzed retrospectively. According to the quartile of interdialysis systolic blood pressure-coefficient of variation (SBP-CV), patients were divided into four groups, and clinical data, biochemical indicators and drug use were compared among 4 groups. Binary logistic regression analysis was used to analyze the associated factors of interdialysis BPV. Results A total of 1010 MHD patients (612 males and 398 females) with the age of (56.3±13.9) years were enrolled in this study. Their dialysis duration was (48.4±36.1) months, and the median of interdialysis SBP-CV was 8.07% (5.72%, 11.34%). According to the quartile of SBP-CV, the patients were divided into four groups: low BPV group (SBP-CV≤5.72%, 253 cases), middle BPV group (5.72%＜SBP-CV≤8.07%, 252 cases), high BPV group (8.07%＜SBP-CV≤11.34%, 253 cases) and extremely high BPV group (SBP-CV＞11.34%, 252 cases), and the dialysis duration, diabetes, ultrafiltration, interdialysis weight gain rate (IDWGR), serum calcium and the proportion of calcium channel antagonist used in the 4 groups were significantly different (all P＜0.05). Logistic multiple regression analysis showed that high IDWGR (OR=1.216, 95%CI 1.108-1.435, P＜0.001) was an independent risk factors for interdialysis BPV in MHD patients, while high ultrafiltration volume (OR=0.436, 95%CI 0.330-0.575, P＜0.001) and calcium channel antagonists used (OR=0.686, 95%CI 0.477-0.986, P=0.042) were independent protective factors. Conclusion High IDWGR is an independent risk factor for interdialysis BPV in MHD patients, while high ultrafiltration volume and calcium channel antagonists used are protective factors for interdialysis BPV in MHD patients.     

Incidence of maintenance hemodialysis patients with fatigue and its related factors

Objective To investigate the incidence of fatigue in maintenance hemodialysis (MHD) patients and its related factors. Methods A total of 289 patients on MHD between January 2016 and March 2017 in hemodialysis centers of the First Affiliated Hospital of Xinjiang Medical University, Xinjiang Yili Kazak Autonomous Prefecture Friendship Hospital, and Yili Prefecture Hospital were enrolled. Internationally standard fatigue rating scale (FAI) was applied to assess the incidence of fatigue in MHD patients, and subjective comprehensive nutrition assessment (SGA) protein energy wasting rating scale was used to assess protein energy wasting (PEW) conditions. All patients were divided into the fatigue group and the non-fatigue group according to the FAI score. The clinical data and the blood biochemical indicators in two groups were compared. The risk factors of fatigue in MHD patients were analyzed by logistic regression method. Results The incidence of fatigue was 83.0% in MHD patients, and the rate of PEW was 62.6%. Blood total cholesterol in the fatigue group was lower than that of the non-fatigue group (P＜0.05). The difference between SGA scores of two groups had statistical significance (P＜0.001). Single factor logistic regression analysis results showed that higher SGA score (OR=1.312, 95%CI: 1.163-1.481, P＜0.001), lower blood total cholesterol (OR=0.661, 95%CI: 0.496-0.880, P=0.005) were risk factors of fatigue in MHD patients. Multivariable logistic regression analysis results showed that higher SGA score (OR=5.286, 95%CI: 2.078-13.442, P＜0.001) was an independent risk factor of fatigue in MHD patients. Conclusions The incidence of fatigue and PEW are high in MHD patients. PEW is an independent risk factor of fatigue in MHD patients.     

Risk factors of bone density disorder and vascular calcification in non-dialysis chronic kidney disease patients

Objective To explore the risk factors of bone density disorder and vascular calcification in non-dialysis chronic kidney disease (CKD) patients. Methods Clinical data of non-dialysis CKD patients who were admitted to the First Affiliated Hospital of Fujian Medical University between January 2013 and June 2014 were retrospectively analyzed. Using dual energy X-ray absorptiometry to evaluate their bone mineral density (BMD) and T value. Patients were divided into normal BMD group (T≥-1), osteopenia group (-2.5＜T＜-1) and osteoporosis group (T≤-2.5). The vascular calcification was evaluated by pectoral computed tomography. Multi-factor stepwise logistic regression analysis was used to assess the risk factors for low bone density and vascular calcification in non-dialysis CKD patients. Results A total of 337 non-dialysis CKD patients were enrolled. There were 110 (32.6%) patients with normal BMD, and 146(43.3%) patients with osteopenia, and 81(24.0%) patients with osteoporosis. Gender, history of hypertension, 25-hydroxy vitamin D and N-terminal osteocalcin shown statistical differences among three groups (all P＜0.05). The incidence rate of 25-hydroxy vitamin D deficiency shown statistical difference among three groups (P=0.012). Further, the rates were increased with the decreased bone mass (χ2=7.100, P=0.008). The other mineral bone disorders, such as hypocalcemia, hyperphosphatemia, low intact parathyroid hormone (iPTH) and high iPTH had no statistical difference among three groups (all P＞0.05). Multi-factor stepwise logistic regression analysis revealed that increased iPTH (OR=1.938), and low bone density (OR=1.724) were independent risk factors for CKD patients with vascular calcification (all P＜0.05), while women (OR=3.312) and vascular calcification (OR=1.742) were independent risk factors for CKD patients with low bone density (all P＜0.05). Conclusion Increased iPTH and low bone density are independent risk factors for non-dialysis CKD patients with vascular calcification, while women and vascular calcification are independent risk factors for non-dialysis CKD patients with low bone density.     

胰腺术后胰瘘发生相关危险因素分析（附303例胰腺手术报告）

目的 探讨影响病人胰腺手术后胰瘘发生率的危险因素。方法 回顾性分析2012年2月至2015年1月中国医科大学附属第一医院收治的303例行胰腺手术病人资料,其中术后发生胰瘘50例。对影响术后胰瘘发生的相关因素进行单因素分析及Logistics回归分析。结果 单因素分析结果显示,影响术后胰瘘发生的因素包括性别、病理类型、胰管扩张、手术时间、术中出血量、术前血红蛋白、术前血清总胆红素、术后血清总胆红素（P<0.05）。非条件Logistic回归分析结果显示,影响术后胰瘘发生的独立危险因素为：性别（OR=12.001,95%CI 3.049~47.230,P<0.05）、病理类型（OR=1.605,95%CI 1.108~2.324,P<0.05）、胰管扩张（OR=1.177,95%CI 0.188~0.468,P<0.05）、手术时间（OR=1.641,95%CI=1.173~2.339,P<0.05）、术中出血量（OR=1.096,95%CI 1.094~1.099,P<0.05）、术前血红蛋白（OR=0.888,95%CI 0.823~0.921,P<0.05）、术前血清总胆红素（OR=1.359,95%CI 1.335~1.381,P=0.010）、术后血清总胆红素（OR=1.030,95%CI 1.064~1.004,P<0.05）。结论 男性、手术前后血清胆红素浓度高、壶腹部癌或十二指肠癌是胰瘘发生的独立危险因素,而胰管扩张则可减少胰腺手术后胰瘘的发生。     

Relationship between low vitamin D level and metabolic syndrome in maintenance hemodialysis patients

Objective To evaluate the relationship between low vitamin D level and metabolic syndrome (MS) in maintenance hemodialysis (MHD) patients. Methods A total of 143 patients who had received MHD from Jan 2016 to Jan 2017 in the dialysis center of our hospital were enrolled. Their clinical and laboratory data were collected. The serum 25(OH)D3 levels were measured by chemiluminescence instrument. According to the levels of 25(OH)D3, patients were divided into three groups: sufficient group (＞30 μg/L), insufficient group (15-30 μg/L) and deficient group (＜15 μg/L) to explore how the 25(OH)D3 were associated with MS and abnormal metabolic parameters, including central obesity, raised triglycerides (TG), reduced high-density lipoprotein cholesterol (HDL-C), raised systolic blood pressure (SBP), raised diastolic blood pressure (DBP) and increased fasting blood glucose (FBG). The risk factors of MS and abnormal metabolic factors were analyzed by multivariate logistic regression model. Results Among the 143 MHD patients, the median of serum 25(OH)D3 was 24.30(12.90, 29.50) μg/L and the prevalence of MS was 45.45%(65 cases). Among 3 groups the prevalence of MS, the abdominal circumference and the serum TG showed statistical differences, and they increased with the severity of 25(OH)D3 deficiency (all P＜0.05). The body mass indexes of patients in the insufficient and deficient groups were elevated compared with that in the sufficient group (all P＜0.05). SBP, TG and FBG in deficient group were significantly higher but HDL-C was lower than those in the other two groups (all P＜0.05). The more abnormal metabolism existed, the lower 25(OH)D3 levels patients had (H=61.316, P＜0.001). Multivariate logistic regression analysis showed that in MHD patients low 25(OH)D3 negatively correlated with MS (OR=0.889, 95%CI 0.846-0.934, P＜0.001) and abnormal metabolic factors central obesity (OR=0.913, 95%CI 0.874-0.953, P＜0.001), raised TG (OR=0.932, 95%CI 0.894-0.971, P=0.001), reduced HDL-C (OR=0.901, 95%CI 0.845-0.959, P=0.001), raised SBP (OR=0.898, 95%CI 0.847-0.953, P＜0.001) and raised FBG (OR=0.956, 95%CI 0.920-0.994, P=0.024). Conclusions The prevalence of MS is high in MHD patients and low levels of 25(OH)D3 may be an independent risk factor for MS and abnormal metabolic factors.     

神经外科手术患者医院获得性肺炎的危险因素分析

目的探讨神经外科手术后患者医院获得性肺炎（HAP）的危险因素,为医院相关控制措施的制定提供理论依据。 方法采用非条件Logistic回归分析及χ²检验分析533例神经外科手术患者的临床资料,探索HAP发生的危险因素。 结果纳入的研究对象中共89例发生HAP,感染率为16.70%;采用χ²检验进行单因素分析结果显示,差异具有统计学意义的指标为患者年龄、手术类型、麻醉类型、手术时间、术中失血量、美国麻醉师协会（ASA）评分、植入物、应用抗菌药物、术前住院天数、术后住院天数及全部住院天数（P均< 0.05）;进一步Logistic多因素回归分析发现,年龄（OR = 4.08,95%CI：2.18～7.65）、ASA评分（OR = 4.44,95%CI：2.06～9.59）及全部住院天数（OR = 2.90;95%CI：1.21～6.97）是HAP的独立危险性因素;而择期手术（OR = 0.54;95%CI：0.30～0.97）及使用抗菌药物（OR = 0.31;95%CI：0.12～0.79）是独立的保护性因素。 结论针对危险性因素做好有效的预防是控制医院获得性肺炎的关键。     

Incidence and mortality of acute kidney injury in coronary care unit: a retrospective study from a single center

Objective To evaluate the incidence and mortality of acute kidney injury (AKI) in coronary care unit (CCU), and to identify the risk factors of the incidence of AKI and the mortality of CCU patients. Methods A total of 414 patients in CCU from January 1, 2014 to June 1, 2015 at Zhongnan Hospital of Wuhan University were enrolled. Based on the KDIGO-AKI criteria, these patients were classified into two groups: NAKI group (patients without AKI) and AKI group. Clinical characteristics and laboratory data of two groups were compared. The risk factors of the incidence of AKI and the mortality of CCU patients was analyzed by logistic regression, and then the receiver operating characteristic (ROC) curve was drawn to evaluate the predictive value of these risk factors. Results (1) Among 414 patients, 136(32.9%) patients fulfilled the criteria for AKI, and 14.0% patients in AKI stage 1, 10.9% in AKI stage 2 and 8.0% in AKI stage 3. (2) The total CCU mortality was 15.0%. Mortality of AKI patients in the CCU was 33.3%, higher than 6.1% in patients without AKI (OR=7.735, 95%CI 4.215-14.196, P＜0.001). The mortality worsened with increasing severity of AKI (22.4% for AKI stage 1 group, 37.8% for AKI stage 2 group, 45.4% for AKI stage 3 group). (3) Anemia (OR=8.274, 95%CI 4.363-15.689), history of chronic illness (OR=2.582, 95%CI 1.400-4.760), APACHEⅡ scores (OR=1.813, 95%CI 1.739-1.895), male (OR=3.666, 95%CI 1.860-7.226) were the independent risk factors for AKI, while the normal mean arterial pressure (MAP) (OR=0.292, 95%CI 0.153-0.556) and normal estimated glomerular filtration rate (eGFR) (OR=0.166, 95%CI 0.090-0.306) are the protective factors for AKI (all P＜0.05). (4) AKI was the most powerful independent factor associated with the mortality of CCU patients (OR=7.050, 95%CI 2.970-16.735, P＜0.001). Other independent risk factors for CCU mortality included history of chronic illness, ejection fraction and APACHEⅡ≥15 scores (all P＜0.05), while the normal MAP and normal eGFR were the protective factors (all P＜0.05). (5) For predicting AKI, eGFR displayed an excellent areas under the ROC curve (AUC=0.815, P＜0.001), and for CCU mortality, APACHEⅡ scores had the highest overall correctness of prediction (AUC=0.757 P＜0.001). Conclusions CCU patients have high morbidity of AKI, which is the most powerful independent factor associated with the increased CCU mortality. The eGFR is the best predictor for AKI, and then through the evaluation of eGFR for CCU patients, we can evaluate high-risk groups, make early interventions and then improve the prognosis of CCU patients.     

经皮肾镜术后尿源性脓毒血症相关危险因素的Meta分析

目的分析经皮肾镜碎石取石术（PCNL）术后并发尿源性脓毒血症术前相关危险因素。 方法运用Meta分析方法综合分析2006年1月至2016年12月PCNL术后尿源性脓毒血症相关危险因素的研究文献。 结果共筛选出相关文献18篇,经分析结果显示有9个危险因素差异具有统计学意义（P<0.05）,其OR值及95%CI分别为：女性3.89（2.07,7.31）;年龄（≥60岁）1.71（1.23,2.39）;糖尿病3.15（2.10,4.72）;血常规（白细胞≥10×10⁹/L）2.86 （1.66,4.92）;尿常规（白细胞≥+）2.43（1.35,4.37）;尿培养（阳性）1.60（1.12,2.29）;结石大小（≥2 cm）1.94（1.49,2.54）;鹿角形结石3.07（1.78,5.31）;肾积水（中重度）1.57（1.02,2.43）。 结论高龄（≥60岁）、女性、合并糖尿病或术前感染、结石≥2 cm、鹿角形结石、肾积水较重的患者PCNL术后更易发生尿源性脓毒血症。